A Non-interventional Study on Xarelto for Treatment of Venous Thromboembolism (VTE) and Prevention of Recurrent VTE in Patients With Active Cancer (COSIMO)
A Non-interventional Study on Xarelto for Treatment of Venous Thromboembolism (VTE) and Prevention of Recurrent VTE in Patients With Active Cancer (COSIMO)
This study aims to collect patient reported outcomes and assess treatment satisfaction in active cancer patients treated with rivaroxaban for VTE (venous thromboembolism).
Study Type: Observational
Actual Enrollment: 528 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: COSIMO Cancer Associated Thrombosis - Patient Reported Outcomes With Rivaroxaban. A Non-interventional Study on Patients Changing to Xarelto® for Treatment of Venous Thromboembolism (VTE) and Prevention of Recurrent VTE in Patients With Active Cancer.
Actual Study Start Date: October 11, 2016
Actual Primary Completion Date: November 30, 2018
Actual Study Completion Date: March 28, 2019
Group/Cohort:
- Rivaroxaban
Female and male patients with active cancer and treated with rivaroxaban after a diagnosis of DVT/ and/or PE
| Category | Value |
|---|---|
| Study type(s) | Observational |
| Expected enrolment | 528 |
| Study start date | 11 October 2016 |
| Actual study completion date | 28 March 2019 |